Alnylam (ALNY) Reports Significant Results from ALN-TTR02 Phase I
Go back to Alnylam (ALNY) Reports Significant Results from ALN-TTR02 Phase I| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 225.56 +0.96 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $224.60 | 52 Week High | $109.10 | |||
| Open | $226.27 | 52 Week Low | $31.38 | |||
| Day High | $226.27 | P/E | N/A | |||
| Day Low | $222.01 | EPS | $-1.45 | |||
| Volume | 271,656 | |||||
